DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Masitinib is an investigational drug.
There have been 32 clinical trials for Masitinib. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2011.
The most common disease conditions in clinical trials are Gastrointestinal Stromal Tumors, Mastocytosis, and Sclerosis. The leading clinical trial sponsors are AB Science and [disabled in preview].
Recent Clinical Trials for Masitinib
|Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19||AB Science||Phase 2|
|Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis Unresponsive to Optimal Symptomatic Treatment||AB Science||Phase 3|
|Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients||AB Science||Phase 3|